Presepsin as an Independent Predictor of Initial Antimicrobial Treatment Failure in Acute Genitourinary Infections

Introduction: Acute genitourinary infections are common and may lead to treatment failure and adverse outcomes. Accordingly, early risk stratification is essential for optimizing antimicrobial therapy. Presepsin is a novel biomarker that rises rapidly after infection onset and may enable earlier assessment than conventional markers such as C-reactive protein (CRP) and procalcitonin (PCT). However, its additional predictive value beyond conventional inflammatory markers remains unclear. This study evaluated the independent and additional predictive value of presepsin for treatment failure compared with conventional markers. Methods: We retrospectively analyzed 320 patients with acute genitourinary infections, including 278 with available PCT data. Treatment failure was defined as persistent fever, clinical deterioration (including sepsis or septic shock), need for intensive care, or antibiotic escalation. Clinical variables and laboratory markers (CRP, PCT, lactate, neutrophil-to-lymphocyte ratio, and presepsin) were analyzed using logistic regression. Predictive models with and without presepsin were constructed, and performance was assessed using receiver operating characteristic curves and area under the curve (AUC), with comparisons by DeLong’s test. Results: Treatment failure occurred in 126 patients (39.4%). Presepsin levels were significantly higher in the failure group (p < 0.001) and remained independently associated with treatment failure after adjustment (p = 0.03 overall; p = 0.026 in the PCT subgroup), whereas CRP and PCT were not consistently significant. Adding presepsin modestly increased AUC (0.652 to 0.658 overall; 0.654 to 0.663 in the PCT subgroup), without statistical significance. Models incorporating presepsin demonstrated higher specificity while maintaining comparable overall performance to models including conventional inflammatory markers. Conclusion: Presepsin is an independent predictor of treatment failure and shows comparable performance to CRP- and PCT-based models. Despite only modest gains in overall discrimination, it may serve as a useful adjunctive biomarker for early risk stratification.

Authors

Publication Details

Journal
Urologia Internationalis
Published
2026-11-21
DOI
https://doi.org/10.1159/uin/aewag058
Primary Topic
Sepsis Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Presepsin as an Independent Predictor of Initial Antimicrobial Treatment Failure in Acute Genitourinary Infections

Seon Beom Jo, Mi Mi Oh, Wonku Hwang, Jung-Youn Kim et al.
Urologia Internationalis
Sepsis Diagnosis and Treatment
article

Presepsin as an Independent Predictor of Initial Antimicrobial Treatment Failure in Acute Genitourinary Infections

Seon Beom Jo, Mi Mi Oh, Wonku Hwang, Jung-Youn Kim, Hyo Jong Kim, Sun Tae Ahn, Jong Wook Kim, Hong Seok Park
article en

Abstract

Introduction: Acute genitourinary infections are common and may lead to treatment failure and adverse outcomes. Accordingly, early risk stratification is essential for optimizing antimicrobial therapy. Presepsin is a novel biomarker that rises rapidly after infection onset and may enable earlier assessment than conventional markers such as C-reactive protein (CRP) and procalcitonin (PCT). However, its additional predictive value beyond conventional inflammatory markers remains unclear. This study evaluated the independent and additional predictive value of presepsin for treatment failure compared with conventional markers. Methods: We retrospectively analyzed 320 patients with acute genitourinary infections, including 278 with available PCT data. Treatment failure was defined as persistent fever, clinical deterioration (including sepsis or septic shock), need for intensive care, or antibiotic escalation. Clinical variables and laboratory markers (CRP, PCT, lactate, neutrophil-to-lymphocyte ratio, and presepsin) were analyzed using logistic regression. Predictive models with and without presepsin were constructed, and performance was assessed using receiver operating characteristic curves and area under the curve (AUC), with comparisons by DeLong’s test. Results: Treatment failure occurred in 126 patients (39.4%). Presepsin levels were significantly higher in the failure group (p < 0.001) and remained independently associated with treatment failure after adjustment (p = 0.03 overall; p = 0.026 in the PCT subgroup), whereas CRP and PCT were not consistently significant. Adding presepsin modestly increased AUC (0.652 to 0.658 overall; 0.654 to 0.663 in the PCT subgroup), without statistical significance. Models incorporating presepsin demonstrated higher specificity while maintaining comparable overall performance to models including conventional inflammatory markers. Conclusion: Presepsin is an independent predictor of treatment failure and shows comparable performance to CRP- and PCT-based models. Despite only modest gains in overall discrimination, it may serve as a useful adjunctive biomarker for early risk stratification.

Urologia Internationalis
Sepsis Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon